Equities researchers at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a report issued on Tuesday. The brokerage set a "hold" rating on the software maker's stock.
Separately, Stephens upped their price target on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a report on Friday, January 31st.
Get Our Latest Stock Analysis on MDRX
Veradigm Stock Up 4.8%
NASDAQ:MDRX opened at $4.40 on Tuesday. Veradigm has a 1 year low of $3.80 and a 1 year high of $11.80. The stock has a 50-day simple moving average of $4.32 and a 200-day simple moving average of $6.92.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
